ASX - Delayed Quote • AUD
ImpediMed Limited (IPD.AX)
At close: April 24 at 4:10 PM GMT+10
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Shashi Tripathi | Chief Operating Officer | 642.83k | -- | -- |
| Dr. Parmjot Bains M.D. | MD, Interim CEO & Director | -- | -- | -- |
| Mr. McGregor Grant BEc, C.A., FCIS, GAICD | Interim CFO & Executive Director | -- | -- | -- |
| Mr. Dennis Schlaht | Senior Vice President of R&D and Technology | 478.63k | -- | -- |
| Lisa Prom | Vice President of Sales | -- | -- | -- |
| Ms. Joann Yao | Chief Strategy Officer | -- | -- | -- |
| Dr. Steven Chen M.B.A., M.D. | Chief Medical Center | -- | -- | -- |
| Ms. Leanne Ralph AAICD, ACIS, BBus | Company Secretary | -- | -- | -- |
| Dr. Walton A. Taylor | Medical Director | -- | -- | -- |
ImpediMed Limited
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 76
Description
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Corporate Governance
ImpediMed Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Jul 21, 2024 - Jul 25, 2024
ImpediMed Limited Earnings Call
Related Tickers
CSX.AX CleanSpace Holdings Limited
0.3300
0.00%
VTI.AX Visioneering Technologies, Inc.
0.1450
-17.14%
UBI.AX Universal Biosensors, Inc.
0.1700
0.00%
CYC.AX Cyclopharm Limited
1.7500
-1.69%
RSH.AX Respiri Limited
0.0330
-5.71%
LBT.AX LBT Innovations Limited
0.0190
-5.00%
TRU.AX TruScreen Group Limited
0.0160
0.00%
UCM.AX Uscom Limited
0.0310
0.00%
CMP.AX Compumedics Limited
0.2600
0.00%
CBL.AX Control Bionics Limited
0.0430
0.00%